INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Grant or awardVerified data

Ma Stacey reported ELAN

Director · Elanco Animal Health Inc · Common Stock

Side
A
Value
—
Shares
12.2K
Price
—
Executed
May 21, 2026
Disclosed
May 26, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
May 21 executedMay 26, 2026 disclosed

ELAN · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
27/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 69.6% of prior position

  • Filing timing+6 / 15

    Disclosed 3 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ELAN

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    64 sh
    		Oct 30, 2026Nov 3, 2026
    traded Oct 30, 2026
    		+4dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    63 sh
    		Oct 16, 2026Oct 20, 2026
    traded Oct 16, 2026
    		+4dSEC FORM 4

    Evidence

    5
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    8 sh
    		Oct 16, 2026Oct 20, 2026
    traded Oct 16, 2026
    		+4dSEC FORM 4

    Evidence

    8
    BJ
    Bettington Timothy JSEE REMARKS
    ELANElanco Animal Health Inc
    Open-market sale · 10b5-1 plan
    		SELL$100K
    4,350 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    67 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    9
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    9 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    66 sh
    		Sep 18, 2026Sep 22, 2026
    traded Sep 18, 2026
    		+4dSEC FORM 4

    Evidence

    9
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    9 sh
    		Sep 18, 2026Sep 22, 2026
    traded Sep 18, 2026
    		+4dSEC FORM 4

    Evidence

    11
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    60 sh
    		Sep 4, 2026Sep 9, 2026
    traded Sep 4, 2026
    		+5dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    62 sh
    		Aug 21, 2026Aug 25, 2026
    traded Aug 21, 2026
    		+4dSEC FORM 4

    Evidence

    9
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    8 sh
    		Aug 21, 2026Aug 25, 2026
    traded Aug 21, 2026
    		+4dSEC FORM 4

    Evidence

    37
    OS
    O'Neill ShivGC AND CORP SEC
    ELANElanco Animal Health Inc
    Open-market purchase
    		BUY$94K
    3,998 sh
    		Aug 18, 2026Aug 18, 2026
    traded Aug 18, 2026
    		+0dSEC FORM 4

    Evidence

    37
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Open-market purchase
    		BUY$97K
    4,200 sh
    		Aug 7, 2026Aug 10, 2026
    traded Aug 7, 2026
    		+3dSEC FORM 4

    Evidence

    13
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    9 sh
    		Aug 7, 2026Aug 10, 2026
    traded Aug 7, 2026
    		+3dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    67 sh
    		Aug 7, 2026Aug 10, 2026
    traded Aug 7, 2026
    		+3dSEC FORM 4

    Evidence

    13
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    8 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    60 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    5
    MA
    Modi Rajeev A.SEE REMARKS
    ELANElanco Animal Health Inc
    Grant or award
    		A$1,477
    61 sh
    		Jun 12, 2026Jun 16, 2026
    traded Jun 12, 2026
    		+4dSEC FORM 4

    Evidence

    23
    MS
    Ma StaceyDirector
    ELANElanco Animal Health Inc
    Grant or award
    		A—
    4,678 sh
    		May 21, 2026May 26, 2026
    traded May 21, 2026
    		+5dSEC FORM 4

    Evidence

    13
    VM
    VanHimbergen Robert MEVP and CFO
    ELANElanco Animal Health Inc
    Grant or award
    		A$197
    8 sh
    		Apr 17, 2026Apr 21, 2026
    traded Apr 17, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001872431-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 21, 2026
    Published
    May 26, 2026
    Ingested by INSIDER
    Nov 5, 03:56 UTC
    Last re-read
    Nov 5, 03:56 UTC

    Extracted facts

    Filer
    Ma Stacey
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Elanco Animal Health Inc
    Ticker
    ELAN
    Shares
    12.2K
    Price per share
    $0
    Execution date (reported)
    May 21, 2026
    Owned after transaction
    29.7K shares
    Days from execution to publication
    5

    What this establishes

    Ma Stacey filed this Form 4 reporting a grant or award of ELAN on May 21, 2026. It became public on May 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Ma Staceycik:0001872431
    Issuer
    Elanco Animal Health Inccik:0001739104

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.